Compare SPWH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPWH | NRXS |
|---|---|---|
| Founded | 1986 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.6M | 49.0M |
| IPO Year | 2014 | 2023 |
| Metric | SPWH | NRXS |
|---|---|---|
| Price | $1.41 | $4.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $2.95 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 354.1K | 133.6K |
| Earning Date | 12-04-2025 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,214,723,000.00 | $3,362,320.00 |
| Revenue This Year | $2.62 | $31.05 |
| Revenue Next Year | $0.41 | $137.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 36.89 |
| 52 Week Low | $0.92 | $1.33 |
| 52 Week High | $4.33 | $6.20 |
| Indicator | SPWH | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 55.15 |
| Support Level | $1.36 | $4.33 |
| Resistance Level | $1.55 | $4.82 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 27.50 | 26.44 |
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).